S V Lichtenstein
Overview
Explore the profile of S V Lichtenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurvitch R, Wood D, Tay E, Leipsic J, Ye J, Lichtenstein S, et al.
Circulation
. 2010 Sep;
122(13):1319-27.
PMID: 20837893
Background: Although short- and medium-term outcomes after transcatheter aortic valve implantation are encouraging, long-term data on valve function and clinical outcomes are limited. Methods And Results: Consecutive high-risk patients who...
2.
Jamieson W, Burr L, Miyagishima R, Janusz M, Fradet G, Ling H, et al.
Eur J Cardiothorac Surg
. 2003 Dec;
24(6):873-8.
PMID: 14643803
Objective: The predominant complication of bioprostheses is structural valve deterioration and the consequences of re-operation. Prosthesis choice for aortic valve replacement surgery (bioprostheses and mechanical prostheses), is influenced by valve-related...
3.
Jamieson W, Burr L, Miyagishima R, Janusz M, Fradet G, Lichtenstein S, et al.
Circulation
. 2003 Sep;
108 Suppl 1:II98-102.
PMID: 12970216
Background: The predominant complication of bioprostheses is structural valve deterioration and the consequences of reoperation. The purpose of the study was to determine the mortality and risk assessment of that...
4.
Jamieson W, Lichtenstein S
Surg Technol Int
. 2003 May;
7:229-48.
PMID: 12721987
The advancements in cardiac valvular replacement devices over the past 25 years have left residual problems with biological and mechanical prostheses. The extensive developments were introduced to reduce or eliminate...
5.
Costa M, Carere R, Lichtenstein S, Foley D, de Valk V, Lindenboom W, et al.
Circulation
. 2001 Nov;
104(22):2689-93.
PMID: 11723020
Background: Although it has been suggested that elevation of CK-MB after percutaneous coronary intervention is associated with adverse clinical outcomes, limited data are available in the setting of coronary bypass...
6.
Cook R, Goddard C, Ashe K, Chen K, Lichtenstein S, Walley K
J Invest Surg
. 2001 Oct;
14(4):213-20.
PMID: 11680531
We hypothesized that beta-adrenergic stimulation with isoproterenol during continuous normothermic cardioplegic arrest would enhance the regenerative and regulatory function of the myocardium, resulting in improved cardiac function. We studied isolated...
7.
Fremes S, Tamariz M, Abramov D, Christakis G, Sever J, Sykora K, et al.
Circulation
. 2000 Nov;
102(19 Suppl 3):III339-45.
PMID: 11082411
Background: The Warm Heart Trial randomized 1732 CABG patients to receive warm or cold blood cardioplegia. In the warm cardioplegia patients, nonfatal perioperative cardiac events were significantly decreased and the...
8.
Jamieson W, Miyagishima R, Burr L, Lichtenstein S, Fradet G, Janusz M
J Heart Valve Dis
. 2000 Aug;
9(4):530-5.
PMID: 10947046
Background And Aim Of The Study: The clinical performance of porcine bioprostheses for valve replacement has been evaluated for over three decades by actuarial analysis as the standard for reporting...
9.
Smiseth O, Thompson C, Lohavanichbutr K, Ling H, Abel J, Miyagishima R, et al.
J Am Coll Cardiol
. 1999 Sep;
34(3):802-9.
PMID: 10483963
Objectives: The purpose of this study was to determine the origin of the pulmonary venous systolic flow pulse using wave-intensity analysis to separate forward- and backward-going waves. Background: The mechanism...
10.
Jamieson W, Miyagishima R, Grunkemeier G, Germann E, Henderson C, Fradet G, et al.
Eur J Cardiothorac Surg
. 1999 Aug;
15(6):786-94.
PMID: 10431860
Objective: The experience with the Carbomedics (CM) and the St. Jude Medical (SJM) bileaflet mechanical prostheses was evaluated to determine thromboembolic and hemorrhagic complications and predictive risk factors. Methods: From...